PER 4.76% 10.0¢ percheron therapeutics limited

anp chart, page-1076

  1. 69 Posts.
    lightbulb Created with Sketch. 51
    Hope you're right! However, we need a catalyst to have SP gains.

    I just can't see any news until at least second half of the new calendar year. Unless we have a surprise event such as a takeover bid on the back of prelim data from the trials...

    Long term we will be laughing at today's share price.

    ALWAYS REMEMBER THE WHY! ANP are targeting inflammation - and INFLAMMATION is the cause of so so many health issues!

    Cardiovascular disease, cancer, Alzheimer's disease, obesity, diabetes, and a variety of infectious diseases.... plus everyday issues:

    - Pain
    - Swelling
    - Heat
    - Redness
    - Fever
    - Weight gain
    - Depression or anxiety
    - Fatigue
    - Joint pain
    - Insomnia
    - Skin rash
    - Loss-of-function
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
-0.005(4.76%)
Mkt cap ! $90.15M
Open High Low Value Volume
11.0¢ 11.0¢ 10.0¢ $52.56K 502.5K

Buyers (Bids)

No. Vol. Price($)
9 176914 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 217753 2
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.